Key Drivers
- Strong Cash Flow
- High Intangibles
- Leverage Risk
AIAI Summary
TRLV's NYSE uplist is a real rerating catalyst because it expands the investor base and improves visibility, but the stock is still only investable on the thesis that its strong free cash flow can persist enough to offset meaningful leverage, heavy intangibles, and inconsistent net earnings.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Strong Cash Flow
- •High Intangibles
- •Leverage Risk
TRLV shows improving operating performance and strong cash generation with excellent liquidity, but leverage, intangible-heavy capitalization, and inconsistent net earnings still temper the investment case.
Price Behavior
Key Price Behavior Insights:
- •Base Failed
- •Momentum Weakening
- •Support Test
TRLV broke sharply below its recent $11.50 base, signaling weaker short-term momentum and putting $10.35 support in focus.
Sharp one-day drop after two flat sessions broke the recent base
Sentiment & News
Key News Insights:
- •Historic listing
- •Capital access
- •Sector visibility
Trulieve's NYSE debut marks a historic first for a U.S. marijuana company, signaling broader acceptance in mainstream capital markets.
The listing may boost Trulieve's visibility and investor interest, potentially supporting sentiment without changing near-term fundamentals
Similar Companies in Healthcare
Other companies in the same sector with AI ratings